US2010330667A1PendingUtilityA1

Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level

Assignee: PASTEUR INSTITUTPriority: Jun 1, 2000Filed: Jun 4, 2010Published: Dec 30, 2010
Est. expiryJun 1, 2020(expired)· nominal 20-yr term from priority
C07K 14/001C07K 7/06C07K 7/08C07K 2319/00A61K 49/0013C07K 14/43595Y10S435/968Y10S930/31
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A modified bioluminescent system comprising a fluorescent molecule covalently linked with a photoprotein, wherein said link between the two proteins has the function to stabilize the modified bioluminescent system and allowing the transfer of the energy by Chemiluminescence Resonance Energy Transfer (CRET).

Claims

exact text as granted — not AI-modified
1 . A composition comprising a purified polypeptide, wherein said composition has the functional characteristics to bind calcium ions and to permit a measureable energy, said energy depending of the quantity of calcium bound and of the quantity of polypeptides in said composition in absence of any light excitation. 
     
     
         2 . A purified polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO: 1 to SEQ ID NO: 6. 
     
     
         3 - 7 . (canceled) 
     
     
         8 . A purified polynucleotide having a sequence selected from the group consisting of SEQ ID NO: 7 to SEQ ID NO: 12. 
     
     
         9 - 13 . (canceled) 
     
     
         14 . A polynucleotide linker having a polynucleotide sequence selected from the group consisting of SEQ ID NO: 13 to SEQ ID NO: 17. 
     
     
         15 - 19 . (canceled) 
     
     
         20 . A peptidic linker of at least 5 amino acids and comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 18 to SEQ ID NO: 22. 
     
     
         21 - 27 . (canceled) 
     
     
         28 . A modified bioluminescent system comprising two bioluminescent proteins and a peptide linker according to  claim 20 . 
     
     
         29 . A modified bioluminescent system according to  claim 28 , wherein said two bioluminescent proteins comprise at least an aequorin protein. 
     
     
         30 . A modified bioluminescent system according to  claim 29  comprising the following constituents: aequorin protein and a GFP protein. 
     
     
         31 . (canceled) 
     
     
         32 . A fusion protein of the formula:
   GFP−LINKER−AEQ;
   wherein GFP is green fluorescent protein; AEQ is aequorin; and LINKER is a polypeptide of 4-63 amino acids.   
     
     
         33 . The fusion protein as claimed in  claim 32 , wherein the linker comprises 14-50 amino acids. 
     
     
         34 . The fusion protein as claimed in  claims 32  and  33 , wherein the linker comprises the following amino acids: (Gly Gly Ser Gly Ser Gly Gly Gln Ser [SEQ ID NO: 25] wherein n is 1-5. 
     
     
         35 . The fusion protein as claimed in  claim 34 , wherein n is 1. 
     
     
         36 . The fusion protein as claimed in  claim 34 , wherein n is 5. 
     
     
         37 . A fusion protein for energy transfer from aequorin to green fluorescent protein by Chemiluminescence Resonance Energy Transfer (CRET) following activation of the aequorin in the presence of Ca++, wherein the fusion protein has the formula:
   GFP−LINKER−AEQ;
   wherein GFP is green fluorescent protein; AEQ is aequorin; and LINKER comprises the following amino acids: Gly Gly Ser Gly Ser Gly Gly Gln Ser [SEQ ID NO: 25], wherein n is 1-5; and wherein the fusion protein has an affinity for Ca++ ions and a half-life of at least 24 hours.   
     
     
         38 . A fusion protein as claimed in  claim 37 , wherein the linker includes the amino acid sequence Ser Gly Leu Arg Ser [SEQ ID NO: 26]. 
     
     
         39 . A fusion protein as claimed in  claim 38 , which further comprises a peptide signal sequence for targeting the fusion protein to a cell or to a subcellular compartment. 
     
     
         40 - 41 . (canceled) 
     
     
         42 . A culture as deposited at the C.N.C.M. and containing a plasmid selected from the group consisting of Nos. 2507, 2508, 2509, 2510, 2511 2512, and 2513. 
     
     
         43 - 52 . (canceled)

Join the waitlist — get patent alerts

Track US2010330667A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.